• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (74)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Cerebrovascular Disease  • Dementias  • Neuroendocrinology  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Metabolic Diseases  • Nutritional and Metabolic Disorders, Other  • Public Health  • Obesity  • Review  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Two Roads Converged

Suzanne Craft, PhD

Arch Neurol. 2009;66(3):300-305.

In recent years a rapidly increasing number of studies has focused on the relationship between dementia and metabolic disorders such as diabetes, obesity, hypertension, and dyslipidemia. Etiological heterogeneity and comorbidity pose challenges for determining relationships among metabolic disorders. The independent and interactive effects of brain vascular injury and classic pathological agents such as β-amyloid have also proved difficult to distinguish in human patients, blurring the lines between Alzheimer disease and vascular dementia. This review highlights recent work aimed at identifying convergent mechanisms such as insulin resistance that may underlie comorbid metabolic disorders and thereby increase dementia risk. Identification of such convergent factors will not only provide important insight into the causes and interdependencies of late-life dementias but will also inspire novel strategies for treating and preventing these disorders.

Author Affiliations: Geriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Non-psychiatric comorbidity associated with Alzheimer's disease
Duthie et al.
QJM 2011;104:913-920.
ABSTRACT | FULL TEXT  

Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
Miller et al.
The Annals of Pharmacotherapy 2011;45:1416-1424.
ABSTRACT | FULL TEXT  

Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Gorelick et al.
Stroke 2011;42:2672-2713.
ABSTRACT | FULL TEXT  

Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults: The Framingham Offspring Study
Tan et al.
Diabetes Care 2011;34:1766-1770.
ABSTRACT | FULL TEXT  

Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
Bayer-Carter et al.
Arch Neurol 2011;68:743-752.
ABSTRACT | FULL TEXT  

Life-Course Socioeconomic Position and Incidence of Dementia and Cognitive Impairment Without Dementia in Older Mexican Americans: Results From the Sacramento Area Latino Study on Aging
Zeki Al Hazzouri et al.
Am J Epidemiol 2011;173:1148-1158.
ABSTRACT | FULL TEXT  

Should We Target Insulin Resistance to Prevent Dementia Due to Alzheimer Disease?
Luchsinger et al.
Arch Neurol 2011;68:17-18.
FULL TEXT  

Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
Baker et al.
Arch Neurol 2011;68:51-57.
ABSTRACT | FULL TEXT  

Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers et al.
Neurology 2010;75:1982-1987.
ABSTRACT | FULL TEXT  

Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Lewis et al.
J. Biol. Chem. 2010;285:36958-36968.
ABSTRACT | FULL TEXT  

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
Wright et al.
Neurology 2010;75:864-873.
ABSTRACT | FULL TEXT  

DHA May Prevent Age-Related Dementia
Cole and Frautschy
J. Nutr. 2010;140:869-874.
ABSTRACT | FULL TEXT  

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-{beta} Peptide Metabolism
Vingtdeux et al.
J. Biol. Chem. 2010;285:9100-9113.
ABSTRACT | FULL TEXT  

Advances in Vascular Cognitive Impairment
Gorelick and Bowler
Stroke 2010;41:e93-e98.
FULL TEXT